Literature DB >> 17052660

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

Sarah-Michelle Orton1, Blanca M Herrera, Irene M Yee, William Valdar, Sreeram V Ramagopalan, A Dessa Sadovnick, George C Ebers.   

Abstract

BACKGROUND: Incidence of multiple sclerosis is thought to be increasing, but this notion has been difficult to substantiate. In a longitudinal population-based dataset of patients with multiple sclerosis obtained over more than three decades, we did not show a difference in time to diagnosis by sex. We reasoned that if a sex-specific change in incidence was occurring, the female to male sex ratio would serve as a surrogate of incidence change.
METHODS: Since environmental risk factors seem to act early in life, we calculated sex ratios by birth year in 27 074 Canadian patients with multiple sclerosis identified as part of a longitudinal population-based dataset.
FINDINGS: The female to male sex ratio by year of birth has been increasing for at least 50 years and now exceeds 3.2:1 in Canada. Year of birth was a significant predictor for sex ratio (p<0.0001, chi(2)=124.4; rank correlation r=0.84).
INTERPRETATION: The substantial increase in the female to male sex ratio in Canada seems to result from a disproportional increase in incidence of multiple sclerosis in women. This rapid change must have environmental origins even if it is associated with a gene-environment interaction, and implies that a large proportion of multiple sclerosis cases may be preventable in situ. Although the reasons why incidence of the disease is increasing are unknown, there are major implications for health-care provision because lifetime costs of multiple sclerosis exceed pound1 million per case in the UK.

Entities:  

Mesh:

Year:  2006        PMID: 17052660     DOI: 10.1016/S1474-4422(06)70581-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  199 in total

1.  Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.

Authors:  Gil Benedek; Jun Zhang; Ha Nguyen; Gail Kent; Hilary A Seifert; Sean Davin; Patrick Stauffer; Arthur A Vandenbark; Lisa Karstens; Mark Asquith; Halina Offner
Journal:  J Neuroimmunol       Date:  2017-06-21       Impact factor: 3.478

Review 2.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

Review 3.  Gender differences in autoimmunity associated with exposure to environmental factors.

Authors:  K Michael Pollard
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

4.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 5.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

6.  MHC transmission: insights into gender bias in MS susceptibility.

Authors:  M J Chao; S V Ramagopalan; B M Herrera; S M Orton; L Handunnetthi; M R Lincoln; D A Dyment; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-01-05       Impact factor: 9.910

7.  Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.

Authors:  Kerstin Hellwig; Ralf Gold
Journal:  J Neurol       Date:  2010-09-28       Impact factor: 4.849

Review 8.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

9.  Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.

Authors:  Lillian Cruz-Orengo; Brian P Daniels; Denise Dorsey; Sarah Alison Basak; José G Grajales-Reyes; Erin E McCandless; Laura Piccio; Robert E Schmidt; Anne H Cross; Seth D Crosby; Robyn S Klein
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

10.  Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.

Authors:  James A Rogers; Manoj K Mishra; Jennifer Hahn; Catherine J Greene; Robin M Yates; Luanne M Metz; V Wee Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.